Je was op zoek naar: hokusai (Deens - Engels)

sikkerhed hos patienter med vte (dvt og pe) i hokusai-vte
safety in patients with vte (dvt and pe) in hokusai-vte

tabel 11: blødningshændelser i hokusai-vte-studiet – analyse af sikkerhed i behandlingsperiodena
table 11: bleeding events in hokusai-vte study - safety analysis on-treatment perioda

tabel 10: virkningsresultater fra hokusai-vte-studiet – mitt-population, samlet studieperiode
table 10: efficacy results from the hokusai-vte study - mitt population, overall study period

edoxaban blev administreret sammen med eller uden mad i engage af-timi 48- og hokusai-vte-studierne.
edoxaban was administered with or without food in the engage af-timi 48 and the hokusai-vte studies.

den gennemsnitlige eksponering over for edoxaban 60 mg (herunder 30 mg dosisreduceret) var 2,5 år hos 7.012 patienter i engage af-timi 48 og 251 dage hos 4.118 patienter i hokusai-vte.
the average exposure to edoxaban 60 mg (including 30 mg dose reduced) was 2.5 years among 7,012 patients in engage af-timi 48 and 251 days among 4,118 patients in hokusai-vte.